Highlights of the
Business Year 2018

January

Lonza started 2018 by announcing record-breaking full-year 2017 results in a major transformational year

Read more
Opening research and development center for South America in Salto (BR)
February

Lonza inaugurated a new research & development center for South America in Salto (BR)

Read more

Lonza established a venture capital (VC) fund to invest in consumer health and wellness startups

Read more
March
Opening of the cell-and-genetherapy manufacturing facility in Pearland, Greater Houston, TX (USA)
April

Lonza opened the world’s largest dedicated cell and gene therapy manufacturing facility in Pearland, Greater Houston, TX (USA)

Read more
Lonza's Portsmouth, NH (USA) site
May

Lonza invested in expansion of its Portsmouth, NH (USA) site, including mid-scale biologics

Read more
June
Capsugel - pills
July

Lonza reported strong momentum with organic growth of 8% sales and 11% CORE EBITDA in H1 2018

Read more

1-year anniversary of successful closing of Capsugel acquisition, now fully integrated into Lonza

August
manufacturing facility for nutritional offerings in Greenwood and Ibex Solution buildings
September

Lonza broke ground on an expanded manufacturing facility for nutritional offerings in Greenwood, SC (USA)

Read more

Lonza expanded Ibex Solutions to offer complete product lifecycle management in one location

Read more

Lonza’s Capital Markets Day 2018 outlined sustainable growth plans through focus and investment

Read more
opening of new monoplant for Rubraca® and Cocoon™ autologous technology
October

Clovis Oncology and Lonza celebrated the grand opening of new monoplant for Rubraca®

Read more

Lonza acquired a controlling stake in Octane Biotech to further develop Cocoon autologous technology

Read more
Lonza building Singapore
November

Lonza released the first commercial 2,000 L single-use bioreactor (SUB) batch from Singapore

Read more

Lonza further strengthened focus on its Healthcare Continuum® strategy by signing agreement to divest Water Care business to Platinum Equity

Read more
Lonza building Guangzhou (CN)
December

Lonza announced it was establishing a strategic biomanufacturing base in Guangzhou (CN) utilizing GE Healthcare’s KUBioTM

Read more